Safety of cell therapy with mesenchymal stromal cells (SafeCell): a systematic review and meta-analysis of clinical trials.

Lalu MM, McIntyre L, Pugliese C, Fergusson D, Winston BW, Marshall JC, Granton J, Stewart DJ, Canadian Critical Care Trials Group. · 2012

Read Safety of cell therapy with mesenchymal stromal cells (SafeCell): a systematic review and meta-analysis of clinical trials. by Lalu MM, McIntyre L, Pugliese C, Fergusson D, Winston BW, Marshall JC, Granton J, Stewart DJ, Canadian Critical Care Trials Group. (2012) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/europmc-pmc3485008.txt.

Description

Lalu and colleagues pooled clinical trials to judge the safety of stem-like cell therapy, in a 2012 PLoS ONE paper. The cells, called mesenchymal stromal cells, are drawn from adult tissues and were being tested for many diseases, including stroke and heart damage. Hope ran ahead of safety data, so the team gathered every trial that gave the cells through the bloodstream.

Thirty-six studies covering more than a thousand people met their rules. Pooling the controlled trials showed no link between the cells and infusion harm, organ trouble, infection, death, or cancer. A brief fever after infusion was the one clear signal. Lalu's group calls the therapy apparently safe so far, while urging larger trials with stricter reporting of harms.

Catalog record

CREATORLalu MM, McIntyre L, Pugliese C, Fergusson D, Winston BW, Marshall JC, Granton J, Stewart DJ, Canadian Critical Care Trials Group.
YEAR2012
COLLECTIONPAPERS
FORMATTXT
FILE SIZE38 KB
LICENSECC BY 4.0
RIGHTSCC BY
SOURCEEurope PMC

Source: https://europepmc.org/articles/PMC3485008

Browse the full library · About the Tower of Babel